Both in Pharmaceuticals
Cadrenal Therapeutics vs Jupiter Neurosciences
Over the past year CVKD returned −92.6% and JUNS returned −98.0%; their daily moves had a correlation of -0.04.
CVKD −92.6% JUNS −98.0%Growth of $1, one year, split-adjusted
| Metric | CVKD | JUNS |
|---|---|---|
| Price | $0.9479 | $2.50 |
| Market cap | $3.4M | $3.3M |
| Today | +0.59% | −5.30% |
| 1 month | −13.0% | −3.1% |
| 6 months | −83.0% | −90.7% |
| Year to date | −86.0% | −96.7% |
| 1 year | −92.8% | −98.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 86.9% |
| Net margin | — | −9380.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 51.0× |
| Net cash | $2.4M | -$6.6K |
| Dividend yield | — | — |
| Volatility (60d) | 86.9% | 1,269.5% |
| Short % of float | 9.2% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).